0001225208-20-003782.txt : 20200228 0001225208-20-003782.hdr.sgml : 20200228 20200228191551 ACCESSION NUMBER: 0001225208-20-003782 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200226 FILED AS OF DATE: 20200228 DATE AS OF CHANGE: 20200228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CANGIALOSI LORETTA V CENTRAL INDEX KEY: 0001174449 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 20673573 MAIL ADDRESS: STREET 1: PFIZER INC. ATTN. CORPORATE SECRETARY STREET 2: 235 EAST 42ND ST. CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2020-02-26 0000078003 PFIZER INC PFE 0001174449 CANGIALOSI LORETTA V PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Sr. Vice President, Controller Common Stock 2020-02-26 4 M 0 24155.0000 34.5900 A 131196.0000 D Common Stock 2020-02-26 4 A 0 3797.0000 0.0000 A 134993.0000 D Common Stock 2020-02-26 4 F 0 1290.0000 34.7200 D 133703.0000 D Common Stock 2020-02-26 4 F 0 1943.0000 34.7200 D 131760.0000 D Common Stock 2020-02-26 4 F 0 18438.0000 36.8000 D 113322.0000 D Common Stock 2666.0000 I By Rule 16b-3 Plan Stock Appreciation Rights 34.5900 2020-02-26 4 M 0 24155.0000 0.0000 D 2020-02-26 2020-02-26 Common Stock 24155.0000 0.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Susan E. Grant, by power of atty., for Loretta V. Cangialosi 2020-02-28